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Summary 
 
COMPARING MONTGOMERY COUNTY AND THE 23 COUNTY GROUP 
 Overall, the number of cases of accidental drug overdose deaths increased in both 
Montgomery County (n=504) and the 23 County Group (n=555) from 2010 – June 
2013. In Montgomery County, unintentional drug overdose deaths rose from 120 in 
2010 to 152 in 2012, while in the 23 County Group these numbers increased from 132 
in 2010 to 177 in 2012. 
 
 Opioids (including any pharmaceutical opioids and/or heroin) were the most 
commonly reported drugs in accidental drug overdose deaths across both groups, 
ranging from 86% in the 23 County Group in 2012 to 96% in Montgomery County in 
2010. 
 
 Overall, Montgomery County had a greater proportion of deaths that tested positive for 
cannabis, cocaine and heroin, while the other 23 county data showed a greater 
proportion of decedents testing positive for pharmaceutical opioids and 
methamphetamine (although the number of methamphetamine mentions is quite low). 
 
 The percentage of oxycodone mentions was consistently higher in the 23 County 
Group (26%, for all years combined) than in Montgomery County (18%, for all years 
combined). In the 23 County Group, oxycodone mentions declined from 32% in 2010 
to 20% in 2012. In Montgomery County, oxycodone mentions remained stable 
between 2010 and 2012 at about 20%, but declined to 10% in the first half of 2013. 
 
 The percentage of methadone mentions decreased significantly in both regions from 
highs of about 35% in both groups in 2010 to about 15% in 2012. 
 
 The percentages of pharmaceutical opioid mentions were consistently higher in the 
23 County Group (68%, for all years combined) than in Montgomery County (61%, for 
all years combined), but declined significantly in both regions from 2010 through 2012.  
In Montgomery County, pharmaceutical opioid mentions declined from 76% in 2010 to 
53% in 2012. In the 23 County Group, pharmaceutical opioids declined from 80% of in 
2010 to 60% in 2012. 
 
 The percentage of heroin mentions in each region increased over time, although the 
percentages of heroin mentions remained lower in the 23 County Group. In 
Montgomery County, heroin was mentioned in 33% of the deaths in 2010, 37% in 
2011, and then increased significantly to 57% in 2012. In the other 23 counties, heroin 
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was present in 21% of the deaths in 2010, increasing to 30% in 2011, and then to 44% 
in 2012. 
 
 Since 2012, more accidental overdose cases in Montgomery County tested 
positive for heroin than pharmaceutical opioids. 
 
 Similar to the decline in the percentage of pharmaceutical opioid mentions, the 
percentage of benzodiazepine mentions declined significantly from 2010 to 2012 in 
both regions. In Montgomery County, benzodiazepine mentions decreased 
significantly from 73% in 2010 to 45% in 2012. In the 23 County Group, 
benzodiazepine mentions decreased from 67% in 2010 to 53% in 2012. 
 
 Cocaine mentions were more common the Urban Region, and there were no 
statistically significant changes over time. About 75% of cocaine-positive cases also 
tested positive for levamisole, an adulterant that may have dangerous health risks 
because it suppresses the immune system of those who are exposed to it. 
 
 
COMPARING THE APPALACHIAN, RURAL, SUBURBAN, AND URBAN REGIONS 
 The declines in the percentages of pharmaceutical opioid mentions in Urban 
(Metropolitan), Suburban, and Appalachian Regions over time, are striking. 
 
 The Appalachian Region had the highest proportion of deaths involving 
pharmaceutical opioids in comparison with the other regions, regardless of year. For 
all years combined, pharmaceutical opioids were present in 79% of overdose cases in 
the Appalachian Region, 65% in the Rural Region, 62% in the Suburban Region, and 
61% in Montgomery County. 
 
 Pharmaceutical opioid mentions declined in all areas, excect the Rural Region. 
Between 2010 and 2012, pharmaceutical opioid mentions declined significantly from 
92% to 69% in the Appalachian Region, and from 76% to 53% in the Urban 
(Montgomery County) region. In the Suburban Region, the decline was even more 
substantial, from 82% in 2010 to 48% in 2012. 
 
 In comparison with the other regions, the rural counties are unique with relatively 
consistent percentages of pharmaceutical opioid mentions over time, ranging from 
67% in 2010 to 63% in 2012. Reasons for a lack of decline are unclear. 
 
 The percentage of oxycodone mentions was consistently the highest in the 
Appalachian Region, ranging from 56% in 2010 to 42% in 2011, and then declining 
significantly to 25% in 2012. 
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 Methadone mentions declined significantly in all areas, except the Rural Region. 
In the Suburban Region methadone declined from 43% in 2010 to 20% in 2011, and 
then to 14% in 2012. Methadone mentions were consistent at about 34% in 
Montgomery County in 2010 and 2011, and then declined significantly to 16% in 2012. 
In the Appalachian Region, methadone mentions decreased significantly from 39% in 
2010 to 14% in 2012. 
 
 Heroin mentions remained the most common in the Montgomery County and the 
least common in the Appalachian Region. For all years combined, heroin was 
present in 30% of overdose cases in the Appalachian Region, 38% in the Rural and 
Suburban Regions, and 47% in Montgomery County. 
 
 Heroin mentions became more common in all regions over time, although 
increases in the Rural Region were not statistically significant. Between 2010 and 
2012, heroin mentions increased significantly from 33% to 57% in Montgomery 
County, and from 21% to 50% in the Suburban Region. In the Appalachian Region, 
heroin mentions increased significantly from 8% in 2010 to 25% in 2011, and then to 
39% in 2012. Percentages of heroin mentions were stable in the Rural Region at about 
31% in 2010 and 2011, and then increased to 43% in 2012, although this change was 
not statistically significant. 
 
 Regional differences in benzodiazepine mentions were not statistically 
significant. There were significant declines in benzodiazepine mentions in the 
Suburban Region from about 64% in 2010 to about 40% in 2012, and in the Urban 
Region from 73% in 2010 to 45% in 2012. Changes in benzodiazepine mentions in 
other regions were not statistically significant. 
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Introduction 
 The State of Ohio is experiencing an epidemic of pharmaceutical opioid and heroin 
abuse that has contributed to unprecedented loss of life through unintentional drug overdoses 
(2012 Drug Overdose Deaths, Ohio Department of Health Violence and Injury Prevention 
Program report: March 2014). For example, from 2010 through 2012, unintentional drug 
overdose deaths in Ohio increased from 1,544 to 1,914—a 24% increase (Unintentional Drug 
Overdose Death Rates, 2007—2012, Ohio Department of Health Office of Vital Statistics, 
March 2014). Montgomery County, Ohio, has been one of the state’s epicenters of 
unintentional drug overdose deaths. Unintentional drug overdose deaths increased from 120 
in 2010 to 125 in 2011, and up to 152 in 2012 in Montgomery County.  
 Starting in late 2011 a dramatic increase in the number of accidental drug overdoses 
related to heroin use was observed in Montgomery County. In 2011, 46 (37% of all cases) 
overdose deaths involved heroin, compared to 87 (57%) in 2012. Simultaneously, 
prescription opioids present in drug overdoses declined from being present in 76% of all drug 
overdose cases in 2010 to 66% in 2011, to 53% in 2012. The significant increase in heroin 
mentions in Montgomery County served as the underlying rationale for the main research 
question guiding this study: Are the trends in drug mentions related to unintentional drug 
overdose deaths in Montgomery County similar to, or different from, trends found in drug 
overdose deaths in other Ohio Counties? 
 This study is a collaborative effort between Center for Interventions, Treatment, and 
Addictions Research in the Wright State University Boonshoft School of Medicine and the 
Montgomery County Coroner’s Office, which provided the unintentional drug overdose data 
on which this report is based. In this Report, we compare trends observed in overdose deaths 
in Montgomery County from 2010 through June 2013 with drug overdose data observed in 23 
other Ohio Counties grouped together. We also compare trends in unintentional drug 
overdose deaths in Montgomery County (the only urban county) with trends observed in 
standard regional groupings of the 23 other counties: Suburban; Rural; Appalachian.  
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Methods 
 Data collection: The Montgomery County Coroner's Office Toxicology Laboratory 
provided de-identified data electronically on 1,069 accidental overdose cases from 27 Ohio 
counties that covered a time period between January 1, 2010 and June 30, 2013. Ten cases 
-- 3 cases from Licking County, 3 from Butler, and 4 from Champagne-- were excluded from 
the final sample because they were from counties that contract with Montgomery County 
Coroner's Office Toxicology Laboratory only for back-up autopsy services. As such, the cases 
do not represent all unintentional overdose cases in each county and were deleted. In 
addition to Montgomery County there were 23 other counties included in the study: Adams, 
Athens, Brown, Clark, Clinton, Darke, Fayette, Gallia, Greene, Hardin, Highland, Logan, 
Madison, Meigs, Mercer, Miami, Pickaway, Preble, Ross, Scioto, Shelby, Warren, and 
Washington (Figure 1). 
 
Figure 1. Counties included in the study. 
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 Key variables: Accidental overdose death data included information on demographic 
characteristics, incident county, county of residence, autopsy findings, and toxicology results. 
Toxicology results contained information of specific drug mentions. A drug “mention” means 
that a specific drug was found in a bodily system or fluid of a decedent, not that the drug was 
necessarily the sole cause of death. Most overdose cases involved multiple drugs. The 
presence of more than one drug can result in more than one mention from a single decedent. 
 Note about the time period and reporting criteria: The original scope of work for this 
project included coroner data from 2010-2012. Subsequently, the coroner notified us of the 
availability of January - June 2013 data, which we elected to include in the analysis to obtain 
a more up-to-date picture of trends. However, we emphasize that the 2013 data presented in 
this report reflect trends from the first 6 months only. We also note that due to differences in 
reporting criteria, numbers of accidental drug overdoses in Montgomery County are slightly 
different from those reported in the Montgomery County Poisoning Death Review. 
 Data analysis: Using county of incident, we compare regional trends in overdose 
deaths related to pharmaceutical opioids, heroin, and other drugs. Regional trends are 
compared in two ways: 1) Montgomery County versus all 23 other counties combined (the 23 
County Group); and 2) regional grouping of counties into Appalachian, Rural, Suburban, and 
Urban/Metropolitan (Montgomery County). Data were transposed into SPSS format, and 
SPSS was used to extract all salient demographic and toxicological information and conduct 
analyses. We identified metabolites of selected drugs in the electronic database and 
constructed a rubric for translating toxicological data into relevant counts of drugs that were 
present in a decedent’s system at the time of death. To identify statistically significant 
differences across regions and over time, comparisons were made using χ² tests and logistic 
regression analysis.  
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Results 
 The final sample of 1,059  accidental drug overdose deaths included: 1) Montgomery 
county data (N= 504); and 2) data (N=555) from 23 additional counties (Appendix 1) that 
contract with  Montgomery County Coroner's Office Toxicology Laboratory for autopsies. 
 Total numbers of accidental drug overdose deaths by year are displayed in Figure 2. 
Overall, accidental drug overdose deaths increased from 252 in 2010 to 329 in 2012 (Figure 
2). Preliminary data from 2013 also show a continuing increase. In the first half of 2013, there 
were 184 accidental overdose deaths in Montgomery and other 23 counties combined.   
 
 
 
 
 
 
 
 
252 
294 329 
184 
0
50
100
150
200
250
300
350
2010 2011 2012 2013/June
Figure 2. Total Number of Accidental Drug Overdose Cases by Year 
(N=1,059)  
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Montgomery County vs. All Other Counties 
DEMOGRAPHIC CHARACTERISTICS  
 Out of 1,059 unintentional drug overdose deaths, 504 were from Montgomery County 
and 555 were from the other 23 counties (Appendix I). Table 1 compares the demographic 
characteristics of people who died from unintentional drug overdoses in Montgomery County 
with decedents in the other 23 counties. Overall, there were greater proportions of Whites 
than non-Whites and males than females in both regions. However, Montgomery County had 
a greater proportion of decedents who were “non-White” (12.7% vs 2.9%) and female (40.9% 
vs. 35.7%), but only the race difference between the two regions was statistically significant 
(p< 0.001). The mean age of decedents was 41.96 in Montgomery County and 40.64 in the 
23County Group. 
 
DRUG TRENDS BY REGION AND OVER TIME  
 Overall, there was an increase in the number of cases of accidental drug overdose 
deaths for both Montgomery County and the 23 other counties combined (Figure 3) during 
Table 1. Demographic Characteristics of Accidental Drug Overdose Cases, 2010-June 2013 
 Demographics  Montgomery County 
(N=504) 
All Other Counties 
(N=555) 
All          (N=1,059) 
 Race*            Whites  
                         Non-Whites 
440 87.3% 539 97.1% 979 92.4% 
64 12.7% 16 2.9% 80 7.5% 
Sex                 Female 
                        Male 
206 40.9% 198 35.7% 404 38.2% 
298 59.1% 357 64.3% 655 61.8% 
 Age               Mean (SD) 41.96 (11.51) 40.64 (10.97) 41.27 (11.24) 
 
Race differences between the Montgomery County and all other counties were statistically significant at p<0.001 
120 125 
152 
107 
132 
169 177 
77 
0
50
100
150
200
2010 2011 2012 2013 (Jan-June)
Figure 3. Accidental Drug Overdose  Death Cases Over Time: Montgomery 
County vs. All Other Counties 
Montgomery County All Other Counties
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the 3.5 year period covered by the study. For example, in Montgomery County unintentional 
drug overdose deaths rose from 120 in 2010 to 152 in 2012, while deaths rose from 132 in 
the other 23 counties in 2010 to 177 in 2012. 
 Differences in drug mentions between county groups for all years combined are 
displayed in Table 2. Montgomery County had a greater proportion of deaths that tested 
positive for cannabis, cocaine and heroin, while the other county data showed a greater 
proportion of decedents testing positive for pharmaceutical opioids and 
methamphetamine, although the number of methamphetamine mentions is quite low (Table 
2). Differences in mentions of specific pharmaceutical opioids--methadone, hydrocodone, and 
fentanyl were not statistically significant across groupings, but oxycodone was significantly 
less common in Montgomery County cases, compared to other counties. In addition, 
pharmaceutical opioids in combination with benzodiazepine mentions were more common in 
the 23 County Group than in Montgomery County. 
 
Table 2. Differences of Drug Mentions in Accidental Overdose Deaths for All Years Combined.  
 
DRUGS 
All Years Combined  
(2010-2013, June) 
Statistical significance 
(Chi-Square Test) 
Montg. 
(N=504) 
All Others  
(N=555) 
Alcohol 133 (26.4%) 137 (24.7%) Not significant  
Cocaine 165 (32.7%) 86 (15.5%) Χ
2 
= 43.4. df=1. P<0.001 
Cannabis (THC) 171 (33.9%) 145 (26.1%) Χ
2 
= 7.7, df=1, P=0.006 
Methamphetamine  4 (0.8%) 14 (2.5 %) Χ
2 
= 4.7, df=1, p=0.03 
Benzodiazepines  298 (59.1%) 330 (59.5%) Not significant  
     Benzod. AND Pharm. Opioids 169 (33.5%) 223 (40.2%) Χ
2 
= 5.0, df=1, p=0.025 
Heroin 239 (47.4%) 194 (35.0%) Χ
2 
= 17.0,df=1, p<0.001 
Pharmaceutical  opioids 309 (61.3%) 379 (68.3%) Χ
2 
= 5.7, df=1, p=0.017 
      Hydrocodone 84 (16.7%) 102 (18.4%) Not significant 
      Oxycodone 89 (17.7%) 146 (26.3%) Χ
2 
= 11.4, df=1, p=0.001 
      Methadone 126 (25.0%) 118 (21.3%) Not significant 
      Fentanyl 29 (5.8%) 36 (6.5%) Not significant 
ANY OPIOID 
(Pharm op. AND/OR  heroin) 
469 (93.1%) 505 (91.0%) Not significant 
   Heroin,  NO pharm. Opioids 160 (31.7%) 126 (22.7%) Χ
2 
= 10.9, df=1, p=0.001 
   Pharm. Opioid   AND  heroin 79 (15.7%) 68 (12.3%) Not significant 
   Pharm opioid, NO heroin  230 (45.6%) 311 (56.0%) Χ
2 
=11.4, df=1, p=0.001 
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 Data on drug mentions by county grouping and year are displayed in Table 3. 
 
Table 3. Drug Mentions in Accidental Drug Overdose Deaths by County Grouping and Year (N=1,059). 
 
  
DRUGS 
2010 2011 2012 2013 (Jan-Jun) 
Montg. 
(N=120) 
All 
Others 
(N=132) 
Montg.  
(N=125) 
All 
Others 
(N=169) 
Montg. 
(N=152) 
All 
Others 
(N=177) 
Montg. 
(N=107) 
All 
Others 
(N=77) 
Alcohol 26 
(21.7%) 
29 
(22.0%) 
30 
(24.0%) 
40 
(23.7%) 
41 
(27.0%) 
39 
(22.0%) 
36^ 
(33.6%) 
29*^ 
(37.7%) 
Cocaine 37 
(30.8%) 
24 
(18.2%) 
47 
(37.6%) 
27 
(16.0%) 
49 
(32.2%) 
28 
(15.8%) 
32 
(29.9%) 
7 
(9.1%) 
Cannabis (THC) 46 
(38.3%) 
38 
(28.8%) 
34 
(27.2%) 
43 
(25.4%) 
55 
(36.2%) 
47 
(26.6%) 
36 
(33.6%) 
17 
(22.1%) 
Methamphetamine  1 (0.8%) 2 (1.5%) 0 
(0.0%) 
3 
(1.8%) 
2 
(1.3%) 
6 
(3.4%) 
1 
(0.9%) 
3 
(3.9%) 
Benzodiazepines  87 
(72.5%) 
89 
(67.4%) 
82 
(65.6%) 
106 
(62.7%) 
69*^ 
(45.4%) 
93^ 
(52.5%) 
60^ 
(56.1%) 
42 
(54.5%) 
     Benzod. AND    
     Pharm. Opioids 
56 
(46.7%) 
60 
(45.5%) 
42*^ 
(33.6%) 
76 
(45.0%) 
41^ 
(27.0%) 
61* 
(34.5%) 
30^ 
(28.0%) 
26 
(33.8%) 
Heroin 39 
(32.5%) 
27 
(20.5%) 
46 
(36.8%) 
50 
(29.6%) 
87*^ 
(57.2%) 
78*^ 
(44.1%) 
67^ 
(62.6%) 
39^ 
(50.6%) 
Pharmaceutical  
opioids 
91 
(75.8%) 
105 
(79.5%) 
83 
(66.4%) 
123 
(72.8%) 
80*^ 
(52.6%) 
106*^ 
(59.9%) 
55^ 
(51.4%) 
45^ 
(58.4%) 
      Hydrocodone 28 
(23.3%) 
25 
(18.9%) 
21 
(16.8%) 
31 
(18.3%) 
20^ 
(13.2%) 
29 
(16.4%) 
15 
(14.0%) 
17 
(22.1%) 
      Oxycodone 27 
(22.5%) 
42 
(31.8%) 
24 
(19.2%) 
51 
(30.2%) 
27 
(17.8%) 
36^ 
(20.3%) 
11^ 
(10.3%) 
17 
(22.1%) 
      Methadone 41 
(34.2%) 
47 
(35.6%) 
43 
(34.4%) 
35^ 
(20.7%) 
24*^ 
(15.8%) 
26^ 
(14.7%) 
18^ 
(16.8%) 
10^ 
(13.0%) 
      Fentanyl 9  
(7.5%) 
9  
(6.8%) 
8 
(6.4%) 
9 
(5.3%) 
7 
(4.6%) 
16 
(9.0%) 
5 
(4.7%) 
2 
(2.6%) 
ANY OPIOID 
(Pharm op. 
AND/OR  heroin) 
115 
(95.8%) 
124 
(93.9%) 
112 
(89.6%) 
155 
(91.7%) 
140 
(92.1%) 
152^ 
(85.9%) 
102 
(95.3%) 
74* 
(96.1%) 
   Heroin,  NO  
   pharm. Opioids 
24 
(20.0%) 
19 
(14.4%) 
29 
(23.2%) 
32 
(18.9%) 
60*^ 
(39.5%) 
46^ 
(26.0%) 
47^ 
(43.9%) 
29^ 
(37.7%) 
   Pharm. Opioid    
   AND  heroin 
15 
(12.5%) 
8  
(6.1%) 
17 
(13.6%) 
18 
(10.7%) 
27 
(17.8%) 
32*^ 
(18.1%) 
20 
(18.7%) 
10^ 
(13.0%) 
   Pharm opioid, NO  
   heroin  
76 
(63.3%) 
97 
(73.5%) 
66 
(52.8%) 
105^ 
(62.1%) 
53*^ 
(34.9%) 
74*^ 
(41.8%) 
35^ 
(32.7%) 
35^ 
(45.5%) 
Statistical significance of changes over time: 
*Statistically significant change (at least p≤0.05) compared to prior year data  
^Statistically significant change (at least p≤0.05) compared to 2010 data. 
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Opioid Trends by Region  
 Opioids (including any pharmaceutical opioids and/or heroin) were the most commonly 
reported drugs in accidental drug overdose deaths across both groups (Figure 3). In 
Montgomery County, opioids (heroin and/or pharmaceutical opioids) were found in about 
90% or more of the unintentional drug overdose deaths in each of the 4 years (Table 3; 
Figure 3). Any opioid mentions in the 23 other counties were very similar, with 94% in 2010, 
declining to about 86% in 2012, and then increasing again in 2013 to 96% (Table 3). 
 
 Heroin 
 Overall, heroin mentions were more common in Montgomery County than in the 23 
County Group. For all years combined, about 47% of all accidental overdose death cases in 
Montgomery county tested positive for heroin, compared to 35% for 23 County Group (Table 
2). Over time, heroin mentions remained more common in Montgomery County than in the 23 
County Group: in 2010, heroin was present in about 35% of OD cases in Montgomery county 
and about 21% in 23 County Group; in 2012, these percentages were 57% and 44% 
respectively. 
 
 Both regions experienced increases in heroin-related overdose cases over time, with 
most substantial increases occurring in 2012. For example, heroin-related overdose cases in 
Montgomery County increased from 39 (33%) in 2010 to 87 (57%) in 2012. In the 23 County 
Group, heroin mentions increased from 27 (21%) in 2010 to 78 (44%) in 2012. Preliminary 
data from 2013 suggest the trend of increases in heroin mentions is continuing in both 
regions. In the first half of 2013, almost 63% of all overdose cases in Montgomery County 
and 51% in the 23 County Group tested positive for heroin (Table 3). 
0.0
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70.0
80.0
90.0
100.0
2010 2011 2012 2013 (Jan-June)
Figure 3. Percentage of Overdose Cases that Tested Positive for Opioids 
(Pharmaceutical Opioids and/or Heroin) Over Time  
All Other Counties Montgomery
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Figure 5. Pharmaceutical Opioids and 
Heroin in Accidental Drug OverdoseCases,  
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Pharmaceutical opioids 
 In contrast to heroin trends, pharmaceutical opioid mentions were less common in 
Montgomery County, compared to the 23 County Group. For all years combined, 61% of 
Montgomery County cases tested positive for pharmaceutical opioids compared to 68% in the 
23 County Group (Table 2).Over time, pharmaceutical opioid mentions remained more 
common in the 23 County Group than in Montgomery County. Regional differences in 
pharmaceutical opioid mentions were smaller compared to regional differences in heroin 
mentions.  
2010 2011 2012 2013 (Jan-June)
Pharm Opioids, Other Counties 79.5 72.8 59.9 58.4
Pharm Opioids, Montgomery 75.8 66.4 52.6 51.4
Heroin, Montgomery 32.5 36.8 57.2 62.6
Heroin, Other Counties 20.5 29.6 44.1 50.6
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
Figure 6. Percentage of Heroin and Pharmaceutical Opioid Mentions in Drug 
Overdose Cases Over Time: Montgomety County vs. All Other Counties  
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 While heroin mentions increased, pharmaceutical opioid mentions declined over time in 
both regions. Similar to heroin trends, the most notable changes occurred in 2012. As seen in 
Table 3 and Figures 4, 5, and 6, pharmaceutical opioid mentions in Montgomery County 
declined from 91(76%) in 2010 to 83 (66%) in 2011 and 80 (53%) in 2012 (only changes in 
2012 were statically significant). In the 23 County Group, 105 (80%) cases in 2010, 123 
(73%) cases in 2011, and 106 (60%) in 2012 tested positive for pharmaceutical opioids. 
Logistic regression analysis revealed that 2012 numbers represent a statistically significant 
decline compared to 2010 and 2011 (Table 3). Data from the first half of 2013 suggest that 
pharmaceutical opioid mentions in both regions did not change compared to 2012 data, but 
remained significantly lower than in 2010 (Table 3). 
 Pharmaceutical opioid product mentions differed somewhat by grouping over time 
(Table 3). Although hydrocodone mentions decreased significantly in Montgomery County 
from 23% in 2010 to 13% in 2012, the percentage remained fairly constant in the 23 County 
Group —ranging from 19% in 2010 to 16% in 2012. The percentage of oxycodone was 
significantly higher in the 23 County Group (32% in 2010; 20% in 2012), compared to 
Montgomery County (23% in 2010; 18% in 2012) over time, although the percentage 
decreased significantly from 32% in 2010 to 20% in 2012 in the 23 County Group (Table 3). 
Methadone mentions decreased significantly in both groups in 2012. In both groups, the 
percentage of methadone mentions was almost identical at about 35% in 2010. In 
Montgomery County, methadone mentions remained at 34% in 2011 and then decreased 
significantly to 16% in 2012. In the 23 County Group, methadone mentions decreased to 21% 
in 2011 and then to 15% in 2012 (Table 3). 
 Pharmaceutical Opioids and Heroin: “Concomitant” vs. “Stand-Alone” Cases 
 Figures 7, 8, and 9 display numbers and percentages of cases that tested positive for 
different combinations of illicit opioids: “heroin only” (no pharmaceutical opioids), “heroin and 
pharmaceutical opioids,” and “pharmaceutical opioids only” (no heroin). In both regions, 
cases that tested positive for both heroin and pharmaceutical opioids were far less common 
than “heroin only” or “pharmaceutical only” cases. For all years combined, there were no 
statistically significant regional differences in cases that tested positive for both types of 
opioids. Over time, Montgomery County data showed no statistically significant changes in 
cases that contained both types of opioids. In the 23 County Group, such cases increased 
significantly from 6%-10% in 2010 and 2011 to 18% in 2012. 
 As expected, “heroin only” cases were more common in Montgomery County, while 
“pharmaceutical only” cases were more common in the 23 County Group (Figures 7-9, Table 
2). Between 2010 and 2012, “heroin only” cases increased significantly from 20% to 40% in 
Montgomery County, and from 14% to 26% in the 23 County Group. “Pharmaceutical opioid 
only” cases declined in both regions. In the 23 County Group, a statistically significant decline 
occurred in 2011 and 2012 (from 74% in 2010 to 62% in 2011, and down to 42% in 2012) 
(Figures 7-9, Table 3). In Montgomery County, there were no statistically significant changes 
in “pharmaceutical opioid only” cases in 2011. However, 2012 data show a statistically 
significant decline compared 2010 and 2011 (Table 3). 
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2010 2011 2012 2013 (Jan-June)
Ph. Op., NO Heroin, Other Counties 73.5 62.1 41.8 45.5
Ph. Op., NO Heroin, Montgomery 63.3 52.8 34.9 32.7
Heroin, NO Ph. Op., Montgomery 20.0 23.2 39.5 43.9
Heroin, NO Ph. Op., Other Counties 14.4 18.9 26.0 37.7
Ph. Op. AND Heroin, Montgomery 12.5 13.6 17.8 18.7
Ph. Op. AND Heroin, Other Counties 6.1 10.7 18.1 13.0
0.0
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40.0
50.0
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80.0
90.0
100.0
Figure 9. Percenatges of Pharmaceutical Opioid  and Heroin Mentions Over 
Time: "Concomittant" and "Stand-Alone" Cases in Montgomety County  and 
All Other Counties  
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Figure 8. Opioid-Related Overdose 
Deaths in Montgomery County  
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Figure 7. Opioid-Related Overdose 
Deaths in 23  Other Counties  
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Pharm. opioids, NO heroin
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 Summary of Heroin and Pharmaceutical Opioid Trends 
 In terms of regional differences, pharmaceutical opioid mentions were more common in 
the 23 County Group than in Montgomery County. Conversely, heroin mentions were less 
common in the 23 County Group than in Montgomery County. However, regional differences 
in heroin mentions were greater than regional differences in pharmaceutical opioid mentions 
(Figure 6). 
 In terms of changes over time, pharmaceutical opioid mentions declined while heroin 
mentions increased in both regions. The most notable increases in heroin and decreases in 
pharmaceutical opioid mentions occurred in 2012 both in Montgomery County and in the 23 
County Group. Since 2012, more accidental overdose cases in Montgomery County 
tested positive for heroin than pharmaceutical opioids. In the other 23 counties, heroin 
mentions have not yet equaled pharmaceutical opioid mentions. 
 In both regions, increases in heroin-related mentions were more substantial than 
declines in pharmaceutical opioid mentions. As a result, the overall numbers of opioid-
related deaths increased in both regions, and opioids (pharmaceutical opioid and/or heroin) 
remained the most commonly identified drugs in the accidental drug overdose cases. 
 
Benzodiazepine Trends by Region  
 Overall, there were no statistically significant regional differences in benzodiazepine 
mentions (Table 2). Figure 10 illustrates a fairly clear correspondence between the 
percentage of benzodiazepine mentions in Montgomery County and the 23 County Group 
over time. Similar to pharmaceutical opioid mentions, benzodiazepine mentions declined 
significantly in 2012 in both regions, although the decline was greater in Montgomery County 
than in the 23 County Group. In Montgomery County, benzodiazepines were present in 45% 
of overdose cases in 2012, a statistically significant decline compared to 2010 (73%) and 
2011 (66%). In the 23 County Group, benzodiazepines declined from 67% in 2010 to 53% in 
2012. 
 The 23 County Group had a greater proportion of overdose cases that tested positive for 
both benzodiazepines and prescription opioids (Table 2). Figure 11 shows that both regions 
experienced similar declines in deaths involving both benzodiazepines and prescription 
opioids.  In Montgomery County, the combination of pharmaceutical opioid and 
benzodiazepine mentions decreased significantly from 47% in 2010 to 34% in 2011, and then 
to 27% in 2012.  By comparison, the benzodiazepine/pharmaceutical opioid combination 
remained constant at about 45% in the 23 County Group from 2010 to 2011, and then 
decreased significantly to 35% in 2012. 
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2010 2011 2012 2013 (Jan-June)
All Other Counties 67.4 62.7 52.5 54.5
Montgomery 72.5 65.6 45.4 56.1
0.0
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Figure 10. Percentage of Drug Overdose Cases that Tested Positive for 
Benzodiazepines: 
Montgomery County vs. All Other 23 Counties  
All Other Counties Montgomery
2010 2011 2012 2013 (Jan-June)
All Other Counties 45.5 45.0 34.5 33.8
Montgomery 46.7 33.6 27.0 28.0
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100.0
Figure 11. Percentage of Drug Overdose Cases that Tested Positive for Both 
Benzodiazepines and Pharmaceutical Opioids:  
Montgomery County vs. All Other 23 Counties  
 
All Other Counties Montgomery
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Cocaine-Related Cases and Levamisole  
 Cocaine mentions remained stable over time, but were more common in Montgomery 
County than in the non-urban counties (Table 2, Figure 12). In Montgomery County, cocaine 
mentions increased from 31% to 38% from 2010 to 2011 and then decreased to 32% in 2012, 
but these changes were not statistically significant. In comparison, cocaine mentions were 
consistently lower in the 23 County Group, ranging from 18% in 2010 and 16% in 2012. 
 Out of 1,059 unintentional drug overdose deaths, there were 189 cases that tested 
positive for levamisole. In the U.S., levamisole is approved for use in veterinary medicine to 
treat parasitic infections. It was used in human medicine as an immunomodulator in 
rheumatoid arthritis and colorectal cancer therapy, but is no longer available for human use in 
the U. S. Since 2009, the Drug Enforcement Administration reported an increase in 
levamisole-adulterated cocaine. Levamisole may have dangerous health risks because it 
suppresses the immune system of those who are exposed to it. 
In our data set, almost all (n=187, 99%) of levamisole cases also tested positive for 
cocaine, which suggests that levamisole was consumed as an adulterant of cocaine. Overall, 
about 74.5% of cocaine-positive cases also tested positive for levamisole, with rates 
somewhat higher in Montgomery County (78%) than in all other counties combined (69%). 
 
 
2010 2011 2012 2013 (Jan-June)
All Other Counties 18.2 16.0 15.8 9.1
Montgomery 30.8 37.6 32.2 29.9
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100.0
Figure 12. Percentage of Drug Overdose Cases that  Tested Positive for 
Cocaine 
All Other Counties Montgomery
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Regional Differences: Appalachian, Rural, Suburban, 
and Urban Counties  
 To examine regional differences, the 24 counties were grouped into 4 regions as defined 
by the Ohio Department of Mental Health and Addiction Services. As shown in Table 4, 9 of 
the 24 counties were classified as Appalachian, 9 as Rural, 5 as Suburban, and 1 as Urban 
(Metropolitan) County.  
Table 4. Montgomery and Other 23 Counties Grouped by Region. 
Appalachian (9) Rural (9)  Suburban (5) Urban (1) 
Adams 
Athens 
Brown 
Gallia  
Highland 
Meigs 
Ross 
Scioto  
Washington 
Clinton 
Darke 
Fayette 
Hardin 
Logan 
Mercer 
Preble 
Shelby  
Warren  
Clark 
Greene 
Madison 
Miami 
Pickaway 
Montgomery 
 
DRUG TRENDS BY REGION  
 As shown in Figure 13, the number of accidental drug overdose deaths increased in 
most regions between 2010 and 2012, but there was a decline in the number of deaths in the 
Appalachian Region from 59 deaths in 2011 to 49 deaths in 2012. Although data from the first 
six months of 2013 may indicate a slight decrease in Rural and Suburban accidental drug 
overdose deaths, these are partial data and may not indicate an annual decrease. By 
contrast, there was an apparent increase in the number of deaths in Montgomery County 
during the first six months of 2013. 
 Table 5 provides a comparison of drug mentions by region for all years combined, and 
Table 6 provides data on regional changes over time. There were no statistically significant 
regional differences or changes over time in mentions of alcohol or THC. 
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Figure 13. Numbers of Accidental Drug Overdose Deaths Over Time by Region 
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 Cocaine mentions were more common in Montgomery County than in the other regions. 
For all years combined, cocaine was mentioned in 32.7% of the overdoses in Montgomery 
County, compared to 21.3% in the Suburban Region, 17.3% in Rural Counties, and only 
7.5% in Appalachian Counties (Table 5). There were no statistically significant changes in 
cocaine mentions over time (Table 6). Regional differences in benzodiazepine mentions 
were not statistically significant, when data were analyzed for all years combined (Table 5). 
However, benzodiazepine mentions declined significantly in the Suburban Region from 64% 
in 2010 to 40% in 2012, and in the Urban Region from 73% in 2010 (and 66% in 2011), then  
to 45% in 2012. There were no statistically significant changes in benzodiazepine mentions in 
the Rural and Appalachian Regions.  The most notable regional differences and changes 
over time were observed in mentions of heroin and pharmaceutical opioids. 
Table 5. Drug Mentions by 4 Regions for All Years Combined. 
 
DRUGS 
All Years Combined  
(2010-2013, June) 
Statistical 
significance 
(Chi-Square 
Test)  
Montgomery 
(N=504) 
Suburban 
(N=174) 
Rural  
(N=208) 
Appalachian 
(N=173) 
Alcohol 133 (26.4%) 44 (25.3%) 50 (24.0%) 43 (24.9) Not 
significant 
Cocaine 165 (32.7%) 37 (21.3%) 36 (17.3%) 13 (7.5%) p<0.001 
Cannabis (THC) 171 (33.9%) 39 (22.4%) 53 (25.5%) 53 (30.6%) p=0.14 
Methamphetamine 4 (0.8%) 1 (0.6%) 6  (2.9 %) 7 (4.0%) - 
Benzodiazepines 298 (59.1%) 91 (52.3%) 128 (61.5%) 111 (64.2%) Not 
significant 
     Benzod. AND 
     Pharm. Opioids 
169 (33.5%) 58 (33.3%) 79 (38.0%) 86 (49.7%) p=0.001 
Heroin 239 (47.4%) 66 (37.9%) 78 (37.5%) 50 (28.9%) p<0.001 
Pharmaceutical  opioids 309 (61.3%) 
108 (62.1) 
135 (64.9%) 136 (78.6%) p<0.001 
     Hydrocodone 84 (16.7%) 24 (13.8%) 42 (20.2%) 36 (20.8%) Not 
Significant 
    Oxycodone 89 (17.7%) 35 (20.1%) 44 (21.2%) 67 (38.7%) p<0.001 
    Methadone 126 (25.0%) 39 (22.4%) 43 (20.7%) 36 (20.8%) Not 
significant 
    Fentanyl 29 (5.8%) 9 (5.2%) 12 (5.8%) 15 (8.7%) Not 
significant 
ANY OPIOID 
(Pharm. op. AND/OR  
heroin) 
469 (93.1%) 153 (87.9%) 187 (89.9%) 165 (95.4%) p=0.036 
    Heroin,  NO pharm. op. 160 (31.7%) 45 (25.9%) 52 (25.0%) 29 (16.8%) p=0.001 
    Pharm. op.  AND  heroin 79 (15.7%) 21 (12.1%) 26 (12.5%) 21 (12.1%) Not 
significant 
    Pharm. op., NO heroin 230 (45.6%) 87 (50%) 109 (52.4%) 115 (66.5%) p<0.001 
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Opioid Trends by Region 
 In all regions, the majority of accidental drug overdose death cases contained mentions 
of opioid drugs (including any pharmaceutical opioids and/or heroin). However, rates tended 
to be higher in the Appalachian Region and lower in the Suburban Region (Figure 14). For all 
years combined, regional differences were statistically significant –the rates were 95% in the 
Appalachian region, 90% in the Rural Region, 93% in the Urban Region, and 88% in the 
Suburban Region (Table 5). Over time, there were no statistically significant changes in “any 
opioid” (heroin and/or pharmaceutical opioid) mentions over time in any of the regions (Table 
6) 
 
 Heroin 
 There were significant differences in heroin mentions across the four regions (Table 5). 
Heroin mentions remained the most common in Montgomery County and the least common 
in the Appalachian Region (Figure 15). For all years combined, heroin was present in 30% of 
overdose cases in the Appalachian Region, 38% in the Rural and Suburban Regions, and 
47% in Montgomery County (Table 5). 
 Over time, heroin mentions became more common in all regions, although increases in 
the Rural Region were not statistically significant (Figure 15, Table 6). Between 2010 and 
2012, heroin mentions increased significantly from 33% to 57% in Montgomery County, and 
from 21% to 50% in the Suburban Region.  In the Appalachian Region, heroin mentions 
increased significantly from 8% in 2010 to 25% in 2011, and then to 39% in 2012. 
Percentages of heroin mentions were stable in the Rural Region at about 31% in 2010 and 
2010 2011 2012 2013
Appalachian 97.4 96.6 89.8 100.0
Rural 91.8 90.2 85.7 96.4
Suburban 93.2 87.8 82.8 91.3
Urban/Montgomery 95.8 89.6 92.1 95.3
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Figure 14 . Percentage of OD Cases that Tested Positive for Any Opioid (Heroin 
and/or Pharmaceutical Opioid) Over Time by Regions 
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2011, and then increased to 43% in 2012, although this change was not statistically 
significant (Table 6). 
 In the first half of 2013, heroin mentions in all but the Rural Region remained 
significantly higher, compared to 2010 data (Table 6). In comparison to 2012, preliminary 
data from 2013 indicate increases in heroin mentions from 39% to 50% in the Appalachian 
Region, from 43% to 50% in the Rural Region, and from 57% to 63% in Montgomery County, 
although these changes were not statistically significant (Table 6). We stress these partial 
2013 data may not reflect annual trends. 
  
 
 
 
 Pharmaceutical Opioids  
 Consistent with the Montgomery County and 23 County Group comparison, 
pharmaceutical opioid mentions declined over time in the regional groupings, in most cases. 
The percentage changes in pharmaceutical opioid mentions from 2010 to 2012, in particular, 
are striking and vary substantially by region (Table 6). 
 
 The Appalachian Region had the highest proportion of deaths involving a 
pharmaceutical opioid in comparison with the other regions, regardless of year. For all years 
combined, pharmaceutical opioids were present in 79% of overdose cases in the 
Appalachian Region, 65% in the Rural Region, 62% in the Suburban Region, and 61% in 
Montgomery County (Table 5). 
2010 2011 2012 2013
Appalachian 7.7 25.4 38.8 50.0
Rural 30.6 31.1 42.9 50.0
Suburban 20.5 32.7 50.0 52.2
Urban/Montgomery 32.5 36.8 57.2 62.6
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Figure 15.  Percentage of Heroin Mentions in  Accidental Drug Overdose 
Deaths 
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 Pharmaceutical opioid mentions declined in all areas, excect the Rural Region (Figure 
16). Between 2010 and 2012, pharmaceutical opioid mentions declined significantly from 
92% to 69% in the Appalachian Region, and from 76% to 53% in the Urban (Montgomery 
County) Region. In the Suburban Region, the decline was even more substantial, from 82% 
in 2010 to 48% in 2012 (Table 6, Figure 16). In contrast to other regions, the rural counties 
are unique with relatively consistent percentages of pharmaceutical opioid mentions over 
time, ranging from 67% in 2010 to 63% in 2012. Reasons for a lack of decline in the Rural 
Region are unclear. Partial data from 2013 suggest that pharmaceutical opioid mentions 
remained at lower levels than in 2010, but not different from 2012 data. 
 Pharmaceutical opioid product mentions differed somewhat by regional group over time 
(Table 6). The percentage of oxycodone mentions was consistently the highest in the 
Appalachian Region, ranging from 56% in 2010 to 42% in 2011, and then declining 
significantly to 25% in 2012. As stated above, hydrocodone mentions decreased 
significantly in Montgomery County from 23% in 2010 to 13% in 2012. Hydrocodone 
mentions remained fairly constant in the other regions, ranging from 10% in the Suburban 
Region in 2010 to 24% in the Appalachian Region in 2011. Methadone mentions declined 
significantly in all areas, except the Rural Region. In the Suburban Region methadone 
declined from 43% in 2010 to 20% in 2011, and then to 14% in 2012. Methadone mentions 
were consistent at about 34% in Montgomery County in 2010 and 2011, and then declined 
significantly to 16% in 2012. In the Appalachian Region, methadone mentions decreased 
significantly from 39% in 2010 to 14% in 2012. 
 
2010 2011 2012 2013
Appalachian 92.3 83.1 69.4 65.4
Rural 67.3 65.6 62.9 65.4
Suburban 81.8 69.4 48.3 43.5
Urban/Montgomery 75.8 66.4 52.6 51.4
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Figure 16. Percentage of Accidental Drug Overdose Deaths that Tested 
Positive for Pharmaceutical Opioids 
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Pharmaceutical Opioids and Heroin: “Concomitant” vs. “Stand-Alone” Cases 
  In all four regions, cases that tested positive for both heroin and pharmaceutical 
opioids were far less common than “heroin only” (heroin, but no pharmaceutical opioids) or 
“pharmaceutical only” (pharmaceutical opioids, but no heroin) cases (Table 6). For all years 
combined, there were no statistically significant differences across regions in cases that 
tested positive for both types of opioids (Table 5). Over time, only data from the Rural Region 
showed a statistically significant increase in such cases from 6% in 2010 to 20% in 2012 
(Table 6). 
 As expected, “heroin, no pharmaceutical opioid” cases were more common in 
Montgomery County, while “pharmaceutical opioid, no heroin” cases were significantly more 
common in the Appalachian Region. “Heroin only” cases increased significantly in 
Montgomery County to 40% in 2012 (compared to 20% in 2010 and 23% in 2011). In 2012, 
“heroin only” cases in the Suburban Region also increased to 35%, compared to 11% in 
2010. Rates in the Rural Region remained largely unchanged, while increases in “heroin 
only” cases in the Appalachian Region were not statistically significant due to low numbers 
(Table 6, Figure 17). 
 “Pharmaceutical opioid only” cases declined significantly in the Appalachian region in 
2011 and then again in 2012. In the Suburban and Urban Region, statistically significant 
declines in “pharmaceutical opioid only” cases occurred in 2012. Changes in rates in the 
Rural region were not statistically significant (Table 6, Figure 18). 
 
2010 2011 2012 2013
Appalachian 5.1 13.6 20.4 34.6
Rural 23.1 24.6 22.9 34.5
Suburban 11.1 17.6 34.5 47.8
Urban/Montgomery 20.0 23.2 39.5 43.9
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Figure 17. Regional Trends in "Heroin, No Pharmaceutical Opioids" 
Cases 
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Conclusions 
 Limitations. Although the present study is unlike any we know of in Ohio, it does have 
limitations. Importantly, only 24 of Ohio’s 88 counties are included in the study with most of 
the 23 non-urban counties being in the southern parts of the state. Only one urban county is 
included, but since Montgomery County is one of the state’s epicenters of unintentional drug 
overdose deaths, it provides a meaningful comparison to trends in other parts of the state. 
 Pharmaceutical opioid mentions were more common in the non-urban regions, while 
heroin mentions were more common in the Urban Region (Montgomery County). With the 
exception of the Rural Region, all other areas experienced declines in pharmaceutical opioid 
mentions and significant increases in heroin-related cases. Since 2012, more accidental 
overdose cases in Montgomery County tested positive for heroin than pharmaceutical 
opioids. Overall, increases in heroin-related mentions were more substantial than declines in 
pharmaceutical opioid mentions. As a result, overdose deaths did not decline, and opioids 
(pharmaceutical opioid and/or heroin) remained the most commonly identified drugs in the 
accidental drug overdose cases. 
2010 2011 2012 2013
Appalachian 89.7 71.2 51.0 50.0
Rural 61.5 59.0 42.9 44.8
Suburban 73.3 56.9 32.8 39.1
Urban/Montgomery 63.3 52.8 34.9 32.7
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Figure 18. Regional Trends in "Pharmaceutical opioids, No Heroin" 
Cases  
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 Since accidental drug overdoses are reflective of substance abuse trends, the findings 
indicate that prevention and intervention initiatives across the state should be driven 
generally by common objectives. The opioid epidemics are having the most excruciating 
impacts on the state, because opioid-related accidental overdose deaths, not to mention 
opioid dependence, have unfathomable impacts on families in Ohio and society in general. 
Furthermore, the economic impacts are impossible to calculate. Ohio is losing an important 
percentage of young people, and the results are likely to have negative impacts in the future. 
Targeted interventions are urgently needed to address these epidemics. 
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Appendix 1. Accidental Drug Overdose Deaths by Incident County and Year (N=1,059). 
Incident County Year Total 
2010 2011 2012 2013 
(Jan. -
June)  
Adams 3 4 7 1 15 
Athens 6 12 10 4 32 
Brown 6 10 7 7 30 
Clark 9 18 21 10 58 
Clinton 3 6 12 5 26 
Darke 3 2 6 2 13 
Fayette 3 3 3 0 9 
Gallia 0 1 4 4 9 
Greene 23 20 20 5 68 
Hardin 3 5 2 4 14 
Highland 4 4 5 3 16 
Logan 6 5 7 2 20 
Madison 2 1 1 1 5 
Meigs 1 3 2 1 7 
Mercer 2 2 0 2 6 
Miami 9 10 14 2 35 
Montgomery 120 125 152 107 504 
Pickaway 1 0 2 5 8 
Preble 5 8 10 6 29 
Ross 1 1 0 0 2 
Scioto 16 20 9 4 49 
Shelby 5 5 4 3 17 
Warren 19 25 26 4 74 
Washington 2 4 5 2 13 
Total  252 294 329 184 1059 
Information about the location of cases was derived from the data field “county of incident” as 
reported by the Montgomery County Coroner’s Office. However there were 4 cases in 2013 with 
missing information for the “county of incident.” For this report, county information for these 4 cases  
was determined based on the reporting agency: 2 cases with missing county of incident were  
classified as “Clark County” because they were reported by Clark County Coroner;  1 case was 
classified as “Brown County” because it was reported by Brown County Coroner; 1 case was classified 
as “Gallia County” because it was reported by Gallia County Coroner.   
 
  
 
  
